USING COMBINATORIAL THERAPIES WITH DENDRITIC CELL THERAPIES TO IMPROVE SURVIVAL AND PREVENT RECURRENCE OF BREAST CANCER LEPTOMENINGEAL DISEASE (LMD)
$18,696,738FY2025Defense Health AgencyDOD
H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc.